Lanean...
A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab
BACKGROUND: The angiogenesis inhibitor monoclonal antibody Bevacizumab is presently the standard treatment for numerous neoplasms but particular toxicities are emerging, such as hypertension, haemorrhage, thromboembolism, gastrointestinal perforation, fistulae, and delayed wound healing. The additio...
Gorde:
| Argitaratua izan da: | BMC Urol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6902463/ https://ncbi.nlm.nih.gov/pubmed/31818277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-019-0566-1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|